Nippon Genetics Europe focuses on products for the Life Science community, mainly on DNA/RNA Imaging, DNA Purification, PCR technology and electrophoresis.The development of the Blue/Green LED...
The FDA Has Approved the First New Alzheimer's Disease Treatment in 20 Years (Post)Big news for patients and families affected by Alzheimer's Disease with the FDA approving the first new treatment in 20 years. Biogen's Aducnaumab, a monoclonal antibody, targets amyloid beta plaques
Key Tech (Page)Genie III Genie III is a compact, lightweight and robust instrument suitable for LAMP testing in the field or laboratory. It was specifically designed to run isothermal amplification...
From our partners at Quanterix, a look at going Beyond Cerebrospinal Fluid (CSF) Biomarkers For Alzheimer’s Disease (Post)Improving Alzheimer’s Disease (AD) diagnosis is the first essential step for improving patient care and quality of life. Early, accurate diagnosis is instrumental in giving people with AD and their fa